Business Wire

ABILIFY® (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY® (aripiprazole) Injection, an injectable ...
FiercePharma

First-Line Use of Abilify Has More Than Doubled Over the Past Year for the Treatment of Newly-Diagnosed Patients in Bipolar Diso

Physicians Expect Use of Seroquel XR and Abilify to Increase Over the Next Two Years, According to a New Report from Decision Resources BURLINGTON, Mass., Nov. 16, 2010 /PRNewswire/ -- Decision ...
Medscape

Aripiprazole in the Treatment of Schizophrenia

Abstract and Introduction Clinical Profile of Aripiprazole as Reflected by Clinical Trial Data Use of Aripiprazole in the Treatment of Schizophrenia: Consensus Report Conclusion References Control of ...
Medscape

FDA to Fast-Track Application for Aripiprazole Use in Teen Schizophrenia

June 20, 2007 — A large, international clinical trial in teens with schizophrenia demonstrated that the atypical antipsychotic aripiprazole (Abilify, Otsuka Pharmaceutical Co and Bristol-Myers Squibb) ...
Business Wire

Otsuka and Lundbeck Published Study Results Showing Aripiprazole 2-Month, Ready-to-Use, Long-Acting Injectable is as Well-Tolerated, and Provides Similar Plasma Levels as ...

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd (Otsuka) and H. Lundbeck A/S (Lundbeck) published results from research demonstrating that an investigational ...
FiercePharma

ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Healio

Starting aripiprazole may not increase risk for psychiatric treatment failure

Please provide your email address to receive an email when new articles are posted on . Compared with initiation of another antipsychotic drug, starting aripiprazole after prior antipsychotic exposure ...
EurekAlert!

ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old

The approval is based on results from a four-week, multicenter, randomized, double-blind, placebo-controlled study in pediatric patients (10 to 17 years old) with Bipolar I Disorder that demonstrated ...
FierceBiotech

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depre

ABILIFY is not approved for use in pediatric patients with depression (See Boxed WARNING). ABILIFY may be associated with orthostatic hypotension and should be used with caution in patients with known ...
MedPage Today

Aripiprazole (Abilify) Potentially Useful for Treating Alcohol Dependence

FARMINGTON, Conn., April 3 -- The atypical antipsychotic aripiprazole (Abilify), modified the behavioral and physiological effects of alcohol, according to a preliminary study. Aripiprazole ...